ABTC vs HIVE

Head-to-Head Stock Analysis & Investment Rating

Last Updated: May 10, 2026

ABTC

58.1
AI Score
VS
HIVE Wins

HIVE

61.5
AI Score

Investment Advisor Scores

ABTC

58score
Recommendation
HOLD

HIVE

62score
Recommendation
BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric ABTC HIVE Winner
Forward P/E 81.9672 49.0196 HIVE
PEG Ratio 0 0 Tie
Revenue Growth 403.5% 218.6% ABTC
Earnings Growth 0.0% -99.9% ABTC
Tradestie Score 58.1/100 61.5/100 HIVE
Profit Margin -57.2% -48.6% HIVE
Beta 1.00 1.00 Tie
AI Recommendation HOLD BUY HIVE

Frequently Asked Questions

Based on our detailed analysis, HIVE is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.